Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease.

Deardorff WJ, Grossberg GT.

Drug Des Devel Ther. 2016 Oct 3;10:3267-3279. eCollection 2016. Review.

2.

A case of donepezil-related torsades de pointes.

Kitt J, Irons R, Al-Obaidi M, Missouris C.

BMJ Case Rep. 2015 Oct 5;2015. pii: bcr2015211900. doi: 10.1136/bcr-2015-211900.

3.

Upper gastrointestinal bleed associated with cholinesterase inhibitor use.

Kok KS, Loke Y, Southgate J.

BMJ Case Rep. 2015 Sep 29;2015. pii: bcr2015211859. doi: 10.1136/bcr-2015-211859. Review.

4.

Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.

Kim DH, Brown RT, Ding EL, Kiel DP, Berry SD.

J Am Geriatr Soc. 2011 Jun;59(6):1019-31. doi: 10.1111/j.1532-5415.2011.03450.x. Epub 2011 Jun 7.

5.

Seizures in Alzheimer disease: who, when, and how common?

Scarmeas N, Honig LS, Choi H, Cantero J, Brandt J, Blacker D, Albert M, Amatniek JC, Marder K, Bell K, Hauser WA, Stern Y.

Arch Neurol. 2009 Aug;66(8):992-7. doi: 10.1001/archneurol.2009.130.

6.

Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil.

Suleyman T, Tevfik P, Abdulkadir G, Ozlem S.

Emerg Med J. 2006 Aug;23(8):641-2.

Supplemental Content

Loading ...
Support Center